Description General description A cocktail of three inhibitors that will inhibit alkaline phosphatases as well as serine/threonine protein phosphatases such as PP1 and PP2A. This product is provided as a set of five 1 ml vials. Each vial contains 1 ml phosphatase inhibitor cocktail solubilized in DMSO with the following components: Bromotetramisole oxalate (2.5 mM), Cantharidin (Cat. No. 210155; 500 µM), and Microcystin-LR (Cat. No. 475815; 500 nM). A cocktail of three inhibitors that will inhibit alkaline phosphatases as well as serine/threonine protein phosphatases such as PP1 and PP2A. This product is provided as a set of five 1 ml vials. May be used with cell lysates and tissue extracts, including samples containing detergents. Each vial contains 1 ml phosphatase inhibitor cocktail solubilized in DMSO with the following components: Packaging 1 set in Fibre case Biochem/physiol Actions Cell permeable: no Primary Target Alkaline phosphatases as well as serine/threonine protein phosphatases such as PP1 and PP2A Product does not compete with ATP. Reversible: no Physical form In DMSO. Reconstitution For long-term storage, aliquot and freeze (-20°C). Dilute 1:100 just prior to use. Legal Information Not available for sale outside of the United States.